CompletedNot Applicable

Analysis of Psychoneuroimmunological Parameters of Health in Specific Population Groups in Slovakia

Slovakia700 participantsStarted 2024-01-01

Plain-language summary

This study aims to investigate the links between psychological and biological immunity from the perspective of psychology, epidemiology, and immunology in a general population study sample as well as in a specific group of people in treatment for alcohol addiction.

Who can participate

Age range

18 Years – 50 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria for 'General Slovak Population Sample': * Age between 18 - 50 years * Residency in the respective region for at least five years * Consent to participate in the study Exclusion Criteria for 'General Slovak Population Sample': * Individuals younger than 18 or older than 50 years * Ongoing acute infectious disease on the day of testing * Eligible individuals who do not provide informed consent Inclusion Criteria for the sample 'Individuals receiving inpatient treatment for alcohol addiction at the treatment facility': * Age between 18 - 50 years * Admission to treatment for alcohol addiction * Consent to participate in the study, Treatment completion Exclusion Criteria for the sample 'Individuals receiving inpatient treatment for alcohol addiction at the treatment facility': * Individuals younger than 18 or older than 50 years * Eligible individuals who do not provide informed consent * Drop-out from alcohol addiction treatment

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

The primary outcome measure is the correlation between psychological immunity, current health status and cytokine levels as indicators of biological immune function.

Timeframe: At the time of study enrollment for Group 1, at the time of admission in treatment and after completion of 3 months of treatment for Group 2

Trial details

NCT IDNCT07070180

SponsorComenius University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-15

View on ClinicalTrials.gov More Immunity trials